What is Neurocrine Biosciences's net income?

Neurocrine Biosciences (NBIX) reported net income of $197.9M in Q1 2026.

How has Neurocrine Biosciences's net income changed year-over-year?

Neurocrine Biosciences's net income increased by 2405.1% year-over-year, from $7.9M to $197.9M.

What is the long-term trend for Neurocrine Biosciences's net income?

Over 4 years (2021 to 2025), Neurocrine Biosciences's net income has grown at a 49.1% compound annual growth rate (CAGR), from $96.9M to $478.6M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Neurocrine Biosciences NBIX Net Income

Net Income at other companies

Bristol-Myers SquibbBMY

$2.68B+9.0%

Acadia PharmaceuticalsACAD

$3.64M-80.8%

Crinetics PharmaceuticalsCRNX

-$127.85M-32.1%

Solid Biosciences Inc.SLDB

-$56.74M-44.4%

MapLight Therapeutics, Inc. MPLT

-$60.67M-172%

BridgeBio PharmaBBIO

-$166.56M+1.8%

Segments

By segment

See full

Reportable Segment$197.9M+2,405%

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$17.3B+30.9%

Enterprise value$17.49B+30.2%

P/E25.9×-12.1×

P/S5.6×+0.3×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's net income?: Neurocrine Biosciences (NBIX) reported net income of $197.9M in Q1 2026.
How has Neurocrine Biosciences's net income changed year-over-year?: Neurocrine Biosciences's net income increased by 2405.1% year-over-year, from $7.9M to $197.9M.
What is the long-term trend for Neurocrine Biosciences's net income?: Over 4 years (2021 to 2025), Neurocrine Biosciences's net income has grown at a 49.1% compound annual growth rate (CAGR), from $96.9M to $478.6M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.